Beijing Balance Medical Technology Co., Ltd was founded in 2005. As a leading company with advanced technology on the research and development of animal source material medical devices, the company’s products have been widely used in heart valve replacement and repair, congenital heart disease treatment and soft tissue surgical repair. 12 products have already received CFDA class III medical device approval, during which the prosthetic tissue heart valve (both bovine pericardial valve and porcine valve), pulmonary valved conduit, annuloplasty ring, cardiothoracic surgical biopatch, neurosurgical microvascular decompression felt are the first approved domestic products in the related treatment fields, filled the vacancy of domestic medical devices. The products have been clinically used in more than 300 large hospitals in China such as Beijing Anzhen Hospital, Guangdong General Hospital. The company also has a strong product pipeline including transcatheter heart valves, ophthalmic surgical biopatch, etc., to reinforce market leader position in the related fields and ensure sustainable business growth in the future.
|Full name||Beijing Balance Medical Technology Co., Ltd.|
|Has weighted voting rights structure?||No|
|Earnings Per Share||0.54||-||-|
|R&D expenditure as a % of operating revenue||11.65%||12.75%||14.57%|
|Total Owners' Equity||196.04||133.65||93.85|
|Net Cash Flows-Operating||53.92||46.38||45.07|
|Net Cash Flows-Investing||-0.45||-14.62||-13.38|
|Net Cash Flows-Financing||12.80||-||-19.62|
|Name||No. of Shares Held (mn)||% of Shares Held|
|Li Feng Ling||0.08||0.08%|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.